Addus HomeCare Reports Third Quarter 20... ( $ .14$ .40$ .43$ .04Weighted average ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Addus HomeCare Reports Third Quarter 2010 Results

Date:11/4/2010

$
.14$
.40$
.43$
.04Weighted average number of common shares outstanding:Basic

10,6811,01910,5611,019Diluted

10,6815,16210,5615,167Condensed Consolidated Balance Sheets(Amounts in thousands)(Unaudited)September 30, 2010December 31, 2009AssetsCurrent assetsCash

$
2$
518Accounts receivable, net

75,71270,491Prepaid expenses and other current assets

8,7196,937Deferred tax assets

6,4595,700Income taxes receivable

93732Total current assets

91,59584,378Property and equipment, net

3,1513,133Other assetsGoodwill

63,70259,482Intangible assets, net

14,42313,082Deferred tax assets

64509Other assets

764731Total other assets

78,95373,804Total assets

$
73,699$
,315Liabilities and stockholders' equityCurrent liabilitiesAccounts payable

$
4,600$
3,763Accrued expenses

28,87125,557Current maturities of long-term debt

6,3697,388Deferred revenue

2,1082,189Total current liabilities

41,94838,897Long-term debt, less current maturities

44,15241,851Other long-term liabilities

1,103-Total stockholders' equity

86,49680,567Total liabilities and stockholders' equity

$
73,699$
,315ADDUS HOMECARE CORPORATION AND SUBSIDIARIESCondensed Consolidated Statements of Cash Flows(Amounts in thousands) (Unaudited)For the Nine Months EndedSeptember 30, 2010September 30, 2009Net Income

$
4,491$
5,386Adjustments to reconcile net income to net cash provided by operating activitiesDepreciation and amortization

2,9553,678Deferred income taxes

-(249)Change in fair value of financial instrument

(191)(395)Stock-based compensation

197212Amortization of debt issuance costs

118530Provision for doubtful accounts

3,1582,097Changes in operating assets and liabilities:Accounts receivable

(8,379)(15,366)Prepaid expenses and other assets

(1,782)(1,830)
'/>"/>

SOURCE Addus HomeCare Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10
Related medicine technology :

1. American Association for Homecare Backs Bipartisan Bill to Eliminate Medicare Bidding Program for Home Medical Equipment
2. American Association for Homecare Proposes Strong Anti-Fraud Measures in Medicare, Applauds HHS Testimony Today That Pledges to "Stop Fraud Before it Starts"
3. Home Medical Equipment Providers and Lawmakers Discuss Cost-Effective Role of Homecare During Washington Meeting
4. NewLife Homecare Partners With ChronoMed to Offer Customized Nutritional Program for Bleeding Disorder Community
5. New Jersey Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People with Disabilities
6. New York Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People With Disabilities
7. California Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People with Disabilities Under Medicare
8. Michigan Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People With Disabilities Under Medicare
9. Homecare Provider Testifies on Downside of Medicare Competitive Bidding Program Before House Energy and Commerce Subcommittee
10. Delta Health Technologies ClinicalVirtuoso™ Targets Homecare Therapists
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound

Post Your Comments:

(Date:5/23/2013)... , May 23, 2013 Isis Pharmaceuticals, Inc. ... today announced that management will present a company overview at ... Conference on Thursday, May 30, 2013 at 8:40 a.m. ET ... live audio webcast of the presentation will be available on ... www.isispharm.com . A replay will be available on the ...

(Date:5/23/2013)... TUCSON, Ariz. , May 23, 2013 ... world,s first and only FDA, Health Canada and CE ... announced today that the Glasgow Science Centre in ... visitors annually, is featuring the SynCardia temporary Total ... as part of its $3 million Bodyworks Exhibition, one ...

(Date:5/23/2013)... , May 23, 2013 BioLife Solutions , ... proprietary clinical grade hypothermic storage and ... contract aseptic media manufacturer , today announced its ... Regenerative Medicine Congress 2013 this week in ... ) Dr. Aby J. Mathew, BioLife,s Senior ...

Breaking Medicine Technology:Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2 Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 2 Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 3 BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2 BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3

[0] Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference [0] Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition [0] BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress

... - Results Highlight the Potential of ... Algeta ASA (OSE: ALGETA), the ... BC1-04 study reported today it has completed its,comprehensive phase ... for bone metastases in patients with hormone-refractory,prostate cancer (HRPC). ...

... After eight weeks of treatment, RAD001 halted tumor growth ... with chemotherapy - Based on these promising data, Novartis ... advanced gastric cancer patients- Gastric cancer is the second ... of new cases occurring in East AsiaEAST HANOVER, N.J., ...

Cached Medicine Technology:Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer 2 Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer 3 Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer 4 Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer 5 Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer 6 RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 2 RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 3 RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 4 RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 5 RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments 6

Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments

(Date:5/23/2013)... high-risk neuroblastoma a common tumor that forms in the ... drugs. A study published by Cell Press in the ... reveals a new genomic approach to screen for compounds ... to differentiate, or convert from immature cells to more ... identified a compound that causes neuroblastoma cells to differentiate, ...

(Date:5/23/2013)... 2013 Sika Sarnafil , the ... today announced Imperial Roof Systems of Iowa as the ... dedication to quality during the re-roofing of the SuperTarget ... a Sika Sarnafil Elite contractor and one of Target’s ... is committed to sustainable building practices and they are ...

(Date:5/23/2013)... 23, 2013 Diabetes is one of ... become a nuisance when patients are unfortunate enough to ... the National Diabetes Information Clearinghouse at http://goo.gl/QyhCz , ... risk of developing neuropathy which further shrivels the nervous ... such patients. Such nerve damage affects the whole body ...

(Date:5/23/2013)... May 23, 2013 Professional Insurance Plans, ... the nation to celebrate Fibromyalgia Education and Awareness Month. ... chiropractors across the country, the agency feels that it ... of this syndrome that affects an estimated 10 million ... Association , the definition of Fibromyalgia (FM) is, “a ...

(Date:5/23/2013)... 2013 Retül University , the ... announce the formation of a strategic educational partnership with ... to offer a bike industry first “Positioned for Speed” ... for time trial, road and triathlon bike fit. , ... bike fitters with a Retül University, F.I.S.T. or S.I.C.I ...

Breaking Medicine News(10 mins):Health News:New screening approach uncovers potential alternative drug therapies for neuroblastoma 2 Health News:Sika Sarnafil Announces Recycling Project of the Year Winner 2 Health News:Neuropathy Nerve Damage Can Now Be Reversed With Neuracel 2 Health News:Professional Insurance Plans Encourages the Nation to Celebrate Fibromyalgia Education and Awareness Month 2 Health News:Retül, Ero Sports and Alphamantis Partner for Industry First Aero Fit Course 2 Health News:Retül, Ero Sports and Alphamantis Partner for Industry First Aero Fit Course 3

[0] New screening approach uncovers potential alternative drug therapies for neuroblastoma [0] Sika Sarnafil Announces Recycling Project of the Year Winner [0] Neuropathy Nerve Damage Can Now Be Reversed With Neuracel [0] Professional Insurance Plans Encourages the Nation to Celebrate Fibromyalgia Education and Awareness Month [0] Retül, Ero Sports and Alphamantis Partner for Industry First Aero Fit Course

... Mark,s Breathe Easy Tour, Inspires Those with Chronic Lung Disease to ... ... SAN DIEGO, July 24 SeQual Technologies Inc. (SeQual),announced today the ... the American Lung,Association of California and Seton Medical Center intended to ...

... PALO ALTO, Calif., July 24 Horizon Therapeutics, ... Timothy P.,Walbert has been named president, chief executive ... Horizon Therapeutics., "Tim has a long, proven ... the pain and arthritis areas," said George,Tidmarsh, M.D., ...

... Free Diabetes Education and Cholesterol ... Screenings to Race Spectators, INDIANAPOLIS, Ind., July ... and Polymer Technology Systems,Inc. as a partner in the recently announced ... as cholesterol,screenings at the IndyCar Series during the 2008 racing season., ...

... $0.51 from $0.38 in ... - Record diluted EPS increased 30.2 percent to $0.56 from $0.43 in, second-quarter 2007, excluding ... from the ... - Specialty revenues increased 32.6 percent to a record of nearly $2.0 ...

... Mass., July 24 Tepha, Inc., a developer ... resorbable polymers, announced,today that it has appointed John ... and Chief Operating Officer. Mr. Hartnett joins Tepha,following ... which he,progressed from field sales, to marketing management, ...

... BEIJING, July 24 /Xinhua-PRNewswire-FirstCall/ -- China Medical,Technologies, ... a leading China-based,medical device company that develops, ... high intensity focused ultrasound tumor,therapy systems, today ... results for the first quarter ended June ...

SeQual Technologies, American Lung Association of California and Seton Medical Center Partner to Support Survivor & Cyclist in 500-Mile California Ride Horizon Therapeutics Names Timothy P. Walbert as President and CEO Eli Lilly and Company and Vision Racing Sponsor Vision Wellness Tour at the IndyCar Series Across the Country Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance Tepha Announces Appointment of John Hartnett as Executive Vice President and Chief Operating Officer China Medical Technologies to Announce Financial Results for the First Quarter Ended June 30, 2008 on August 4, 2008

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

Medicine Products:

Morphine Quantitation, Serum or Plasma Monoethylglycinerylidide, Urine Moricizine (Ethmozine), Serum or Plasma Mono/Dizygotic Differentiation